Clinical Profile, Practice Pattern, and Outcomes With First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data From Resource-Constrained Settings

INTRODUCTION: ALK inhibitors are one of the success stories in precision medicine for treating patients with advanced ALK-positive NSCLC. Nevertheless, developing countries have substantial constraints in using ALK inhibitors, with limited data from India. METHODS: An audit of a prospectively collec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Akhil, Noronha, Vanita, Patil, Vijay, Menon, Nandini, Joshi, Amit, Kumar, Amit, Singh, Ajay Kumar, Mahajan, Abhishek, Janu, Amit, Kumar, Rajiv, Pai, Trupti, Chougule, Anuradha, Shetty, Omshree, Prabhash, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841022/
https://www.ncbi.nlm.nih.gov/pubmed/36654881
http://dx.doi.org/10.1016/j.jtocrr.2022.100443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841022/
https://www.ncbi.nlm.nih.gov/pubmed/36654881
http://dx.doi.org/10.1016/j.jtocrr.2022.100443

Ejemplares similares